MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 1, 2006; DOI: 10.1124/mol.106.027458


0026-895X/06/7005-1693-1699$20.00
Mol Pharmacol 70:1693-1699, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.027458v1
70/5/1693    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mao, D.
Right arrow Articles by Kellar, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mao, D.
Right arrow Articles by Kellar, K. J.

Heterogeneity of Nicotinic Cholinergic Receptors in Rat Superior Cervical and Nodose Ganglia

Danyan Mao, Robert P. Yasuda, Hong Fan, Barry B. Wolfe, and Kenneth J. Kellar

Department of Pharmacology and Interdisciplinary Program in Neuroscience, Georgetown University School of Medicine, Washington, DC (D.M., R.P.Y., B.B.W., K.J.K.); and Department of Radiology, Johns Hopkins University Medical School, Baltimore, Maryland (H.F.)

Nicotinic cholinergic receptors (nAChRs) are present in ganglia in the peripheral nervous system. In autonomic ganglia, they are responsible for fast synaptic transmission, whereas in the sensory ganglia and sensory neurons, they may be involved in modulation of neurotransmission. The present study measured nAChRs in several rat autonomic ganglia: the superior cervical ganglia (SCG), sensory nodose ganglia, stellate ganglia, and pelvic ganglia. The densities of the heteromeric nAChRs determined by receptor binding assay in those four ganglia are 481, 45, 9, and 11 fmol/mg protein, respectively. Immunoprecipitation studies with subunit-specific antibodies showed that a majority of the nAChRs in the SCG and nodose ganglia contain the {alpha}3 and beta4 subunits, but a significant percentage of the nAChRs in these ganglia also contain {alpha}5 and beta2 subunits. A small percentage of the nAChRs in nodose ganglia also contain {alpha}2 and {alpha}4 subunits. Sequential immunoprecipitation assays indicated that in the SCG, all {alpha}5 subunits are associated with {alpha}3 and beta4 subunits, forming the mixed heteromeric {alpha}3beta4{alpha}5 subtype. A receptor composed of {alpha}3, beta2, and beta4 subunits in the SCG was also detected. In rat SCG, we found the following distribution of nAChRs subtypes: 55 to 60% simple {alpha}3beta4 subtype, 25 to 30% {alpha}3beta4{alpha}5 subtype, and 10 to 15% {alpha}3beta4beta2 subtype. These findings indicate that the nAChRs in SCG and nodose ganglia are heterogeneous, which suggests that different receptor subtypes may play different roles in these ganglia or may be activated under different conditions.


Received June 2, 2006; accepted August 1, 2006

Address correspondence to: Dr. Kenneth J. Kellar, Department of Pharmacology, Georgetown University School of Medicine, Washington, DC 20057. E-mail: kellark{at}georgetown.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics